Barry E. Greene occupies the position of President of Alnylam Pharmaceuticals, Inc. Dr. Greene is also on the board of Acorda Therapeutics, Inc. and Karyopharm Therapeutics, Inc. and Chief Medical Officer at Vicarious Surgical, Inc.

In his past career he was Partner at Andersen Consulting LLP (GB), Vice President-Marketing & Customer Services at AstraZeneca Plc and Vice President-Strategic Integration at AstraZeneca Pharmaceuticals LP (a subsidiary of AstraZeneca Plc), General Manager-Oncology Division at Takeda Oncology Co., Chief Business Officer & Executive Vice President at Mediconsult.com, Inc. and Partner at Accenture Ltd.

He received an undergraduate degree from the University of Pittsburgh.